U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07574242) titled 'Effect of vitk2 on Atopic Dermatitis Pediatrics Patients' on Jan. 06.
Brief Summary: investigate the effectiveness and safety of adding vitamin K2 at a dose of 45 mg/day for 12 weeks to conventional therapy for paediatric patients with moderate to severe atopic dermatitis according to SCORAD score
Study Start Date: Aug. 03, 2024
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Intervention:
DIETARY_SUPPLEMENT: vit k2
Vitamin K2 is a fat-soluble vitamin essential for blood clotting, bone health, and heart health, found in animal products and fermented foods.
OTHER: Placebo
placebo
Recruitment Status: COMPLETED
Sponsor...